UniProt ID | AN32A_HUMAN | |
---|---|---|
UniProt AC | P39687 | |
Protein Name | Acidic leucine-rich nuclear phosphoprotein 32 family member A | |
Gene Name | ANP32A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 249 | |
Subcellular Localization | Nucleus. Cytoplasm. Endoplasmic reticulum. Translocates to the cytoplasm during the process of neuritogenesis (By similarity). Shuttles between nucleus and cytoplasm.. | |
Protein Description | Implicated in a number of cellular processes, including proliferation, differentiation, caspase-dependent and caspase-independent apoptosis, suppression of transformation (tumor suppressor), inhibition of protein phosphatase 2A, regulation of mRNA trafficking and stability in association with ELAVL1, and inhibition of acetyltransferases as part of the INHAT (inhibitor of histone acetyltransferases) complex. Plays a role in E4F1-mediated transcriptional repression.. | |
Protein Sequence | MEMGRRIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYDRDDKEAPDSDAEGYVEGLDDEEEDEDEEEYDEDAQVVEDEEDEDEEEEGEEEDVSGEEEEDEEGYNDGEVDDEEDEEELGEEERGQKRKREPEDEGEDDD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Methylation | RRIHLELRNRTPSDV CCEEEECCCCCHHHH | 22.62 | - | |
15 | Phosphorylation | HLELRNRTPSDVKEL EEECCCCCHHHHHHH | 30.60 | 23927012 | |
17 | Phosphorylation | ELRNRTPSDVKELVL ECCCCCHHHHHHHHH | 55.19 | 23927012 | |
20 | Ubiquitination | NRTPSDVKELVLDNS CCCHHHHHHHHHCCC | 50.77 | 21890473 | |
20 | Acetylation | NRTPSDVKELVLDNS CCCHHHHHHHHHCCC | 50.77 | 25953088 | |
27 | Phosphorylation | KELVLDNSRSNEGKL HHHHHCCCCCCCCCC | 36.43 | 23401153 | |
29 | Phosphorylation | LVLDNSRSNEGKLEG HHHCCCCCCCCCCCC | 38.77 | 25159151 | |
68 | Ubiquitination | PKLNKLKKLELSDNR CCCCCCCCCCCCCCC | 58.59 | - | |
75 | Methylation | KLELSDNRVSGGLEV CCCCCCCCCCHHHHH | 29.03 | - | |
77 | Phosphorylation | ELSDNRVSGGLEVLA CCCCCCCCHHHHHHH | 24.73 | 21815630 | |
86 | Ubiquitination | GLEVLAEKCPNLTHL HHHHHHHHCCCCCEE | 49.76 | - | |
86 | Acetylation | GLEVLAEKCPNLTHL HHHHHHHHCCCCCEE | 49.76 | 25953088 | |
87 | S-nitrosylation | LEVLAEKCPNLTHLN HHHHHHHCCCCCEEE | 1.71 | 2212679 | |
96 | Phosphorylation | NLTHLNLSGNKIKDL CCCEEECCCCCCCCH | 38.97 | 72255823 | |
99 | Ubiquitination | HLNLSGNKIKDLSTI EEECCCCCCCCHHHC | 55.44 | 21890473 | |
99 | Acetylation | HLNLSGNKIKDLSTI EEECCCCCCCCHHHC | 55.44 | 25953088 | |
101 | Ubiquitination | NLSGNKIKDLSTIEP ECCCCCCCCHHHCHH | 54.98 | - | |
101 | Acetylation | NLSGNKIKDLSTIEP ECCCCCCCCHHHCHH | 54.98 | 19608861 | |
104 | Phosphorylation | GNKIKDLSTIEPLKK CCCCCCHHHCHHHHH | 37.16 | 30266825 | |
105 | Phosphorylation | NKIKDLSTIEPLKKL CCCCCHHHCHHHHHH | 36.34 | 28857561 | |
110 | Ubiquitination | LSTIEPLKKLENLKS HHHCHHHHHHHCCCC | 67.06 | 21890473 | |
110 | Succinylation | LSTIEPLKKLENLKS HHHCHHHHHHHCCCC | 67.06 | 23954790 | |
110 | Acetylation | LSTIEPLKKLENLKS HHHCHHHHHHHCCCC | 67.06 | 23749302 | |
116 | Ubiquitination | LKKLENLKSLDLFNC HHHHHCCCCCCCCCC | 61.63 | - | |
117 | Phosphorylation | KKLENLKSLDLFNCE HHHHCCCCCCCCCCE | 30.22 | 20873877 | |
123 | Glutathionylation | KSLDLFNCEVTNLND CCCCCCCCEECCHHH | 3.31 | 22555962 | |
123 | S-nitrosylation | KSLDLFNCEVTNLND CCCCCCCCEECCHHH | 3.31 | 19483679 | |
123 | S-nitrosocysteine | KSLDLFNCEVTNLND CCCCCCCCEECCHHH | 3.31 | - | |
126 | Phosphorylation | DLFNCEVTNLNDYRE CCCCCEECCHHHHHH | 16.22 | 21406692 | |
131 | Phosphorylation | EVTNLNDYRENVFKL EECCHHHHHHHHHHH | 20.82 | 21406692 | |
132 | Methylation | VTNLNDYRENVFKLL ECCHHHHHHHHHHHH | 31.70 | - | |
132 | Dimethylation | VTNLNDYRENVFKLL ECCHHHHHHHHHHHH | 31.70 | - | |
137 | Ubiquitination | DYRENVFKLLPQLTY HHHHHHHHHHHHHHC | 44.85 | - | |
143 | Phosphorylation | FKLLPQLTYLDGYDR HHHHHHHHCCCCCCC | 19.45 | 26356563 | |
144 | Phosphorylation | KLLPQLTYLDGYDRD HHHHHHHCCCCCCCC | 16.04 | 26356563 | |
148 | Phosphorylation | QLTYLDGYDRDDKEA HHHCCCCCCCCCCCC | 13.89 | 25884760 | |
150 | Methylation | TYLDGYDRDDKEAPD HCCCCCCCCCCCCCC | 45.61 | - | |
158 | Phosphorylation | DDKEAPDSDAEGYVE CCCCCCCCCCCCCCC | 37.35 | 26657352 | |
163 | Phosphorylation | PDSDAEGYVEGLDDE CCCCCCCCCCCCCCC | 6.19 | 26074081 | |
204 | Phosphorylation | EGEEEDVSGEEEEDE CCCCCCCCCCHHHCC | 53.46 | 15287743 | |
238 | Acetylation | EERGQKRKREPEDEG HHHHHHCCCCCCCCC | 69.05 | 26051181 | |
238 | Methylation | EERGQKRKREPEDEG HHHHHHCCCCCCCCC | 69.05 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
158 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
158 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
158 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
204 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
204 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
204 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AN32A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AN32A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MAP1B_HUMAN | MAP1B | physical | 12807913 | |
XPO1_HUMAN | XPO1 | physical | 11565755 | |
TAF1A_HUMAN | TAF1A | physical | 11163245 | |
SET_HUMAN | SET | physical | 11163245 | |
SET_HUMAN | SET | physical | 17142970 | |
H31_HUMAN | HIST1H3A | physical | 15100215 | |
IMA5_HUMAN | KPNA1 | physical | 16713569 | |
IMA6_HUMAN | KPNA5 | physical | 16713569 | |
IMA7_HUMAN | KPNA6 | physical | 16713569 | |
PRGR_HUMAN | PGR | physical | 15308690 | |
THB_HUMAN | THRB | physical | 15308690 | |
PPARG_HUMAN | PPARG | physical | 15308690 | |
PCBP1_HUMAN | PCBP1 | physical | 21988832 | |
ARC1B_HUMAN | ARPC1B | physical | 22863883 | |
IF4A3_HUMAN | EIF4A3 | physical | 22863883 | |
PDLI5_HUMAN | PDLIM5 | physical | 22863883 | |
RFA2_HUMAN | RPA2 | physical | 22863883 | |
LA_HUMAN | SSB | physical | 22863883 | |
TPD54_HUMAN | TPD52L2 | physical | 22863883 | |
PFD3_HUMAN | VBP1 | physical | 22863883 | |
SAHH2_HUMAN | AHCYL1 | physical | 26344197 | |
AN32B_HUMAN | ANP32B | physical | 26344197 | |
AN32E_HUMAN | ANP32E | physical | 26344197 | |
DMAP1_HUMAN | DMAP1 | physical | 26344197 | |
PAPP1_HUMAN | PAPPA | physical | 26344197 | |
DCAF1_HUMAN | VPRBP | physical | 26344197 | |
VPS72_HUMAN | VPS72 | physical | 26344197 | |
ELAV1_HUMAN | ELAVL1 | physical | 11565755 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-15 AND SER-17, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158, AND MASSSPECTROMETRY. |